The study drug is a potential new treatment for postoperative delirium.

1 nights
1 follow-up phone call + 1 visits

The study drug is a potential new treatment for postoperative delirium. This can occur after long surgeries and causes impairment in attention and awareness. The condition is caused by sleep/wake cycle disturbances and mainly affects older people.

This clinical trial has been approved by an independent ethics committee, and you will be reimbursed for your time.

Call us on 1800 243 733 to discuss your eligibility today!

Eligibility

Biological Sex Healthy people
Age 50 - 75 years old
Weight Weigh more than 45kg
BMI 18 - 32 kg/m²
Medication Not taking any other medications (hormone replacement therapy, cholesterol medication, and antidepressants may be permitted on a case-by-case basis)
Medical History No significant medical history
Smoking History Non-smokers only